Category Archives: National Standards for Cognitive Testing

National Standards for Cognitive Testing

Cognitive Screening & Testing Report Released

Computerized Cognitive Assessment Products – Neurocognitive Screening for ADHD, Memory Loss, Alzheimer’s, Dementia, Traumatic Brain Injury Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include: An Aging Global Population: 500 million people in the […]

Early Detection Tests for Alzheimer’s Disease: Introduction

Rising Dementia Rates are a Global Health Trend A positive aspect of rising living standards in most of the world has been a significant improvement in worldwide average life expectancies, increasing from 52 years in 1960 to 69 years in 2009. Regional differences are even more striking — the average life expectancy for a person […]

Detecting Alzheimer’s Disease 20 Years Before Symptoms Appear

A research team at Washington University School of Medicine just published the results of a study that looked at a number of cognitive changes and biomarkers that can be used to predict the risk of Alzheimer’s Disease long before symptoms appear – in some cases up to 20 years before symptom onset. The study, published […]

New Progress on a Blood Test for Alzheimer’s Disease

The PLoS ONE science journal published an interesting study performed by the Brain and Aging Research Program at the University of New South Wales in Sydney, Australia. The study sampled apolipoprotein levels in blood samples from over 600 older adults participating in the ongoing Sydney Memory and Aging Study. Apolipoproteins are proteins that transport cholesterol […]

The Pros and Cons of Amyvid for Amyloid Beta Imaging

A topic that received a lot of attention at the University of California San Diego School of Medicine update on Alzheimer’s research was the use of Eli Lilly’s Amyvid for detection of amyloid beta deposits in the brain, one of the physical signatures of Alzheimer’s Disease. Dr. Gil Rabinovici, MD, a physician and researcher at […]

Early Screening and Diagnosis of Alzheimer’s is key part of NAPA 2025

The U.S. Department of Health and Human Services (HHS) released a draft road map on February 22 that lays out the national strategy to address the rapidly rising rates of Alzheimer’s disease and other types of dementia. There are over 5.4 Million people in the US living with dementia today, and this is expected to […]

The Benefits of Annual Screening for Cognitive Health

Routine health screenings are now common for a variety of conditions like hypertension, diabetes, and glaucoma. Many health insurance plans, including Medicare, provide no cost or low cost health screenings to their members. The main intent behind these preventive health screenings, or wellness screenings, is to provide an early warning system for both consumers and […]